Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial

Marcia S. Brose, Bruce G. Robinson, Steven I. Sherman, Barbara Jarzab, Chia Chi Lin, Fernanda Vaisman, Ana O. Hoff, Erika Hitre, Daniel W. Bowles, Suvajit Sen, Jennifer W. Oliver, Kamalika Banerjee, Bhumsuk Keam, Jaume Capdevila

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences